Fani‐Marlen Roumelioti

ORCID: 0000-0003-0112-6601
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genomics and Chromatin Dynamics
  • CRISPR and Genetic Engineering
  • Telomeres, Telomerase, and Senescence
  • Epigenetics and DNA Methylation
  • RNA Interference and Gene Delivery
  • MicroRNA in disease regulation
  • Chromosomal and Genetic Variations
  • Genomic variations and chromosomal abnormalities
  • Cancer Research and Treatments
  • Musculoskeletal synovial abnormalities and treatments
  • Cancer-related gene regulation
  • Cancer-related Molecular Pathways
  • Cancer Genomics and Diagnostics
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Microtubule and mitosis dynamics
  • Circular RNAs in diseases
  • Chronic Myeloid Leukemia Treatments
  • DNA Repair Mechanisms
  • Cytokine Signaling Pathways and Interactions
  • Advanced biosensing and bioanalysis techniques
  • RNA modifications and cancer
  • Ubiquitin and proteasome pathways
  • Genetics and Neurodevelopmental Disorders

National and Kapodistrian University of Athens
2024

Alexander Fleming Biomedical Sciences Research Center
2024

Academy of Athens
2016-2021

Biomedical Research Foundation of the Academy of Athens
2016-2021

Scientific Report19 October 2016Open Access Transparent process Alternative lengthening of human telomeres is a conservative DNA replication with features break-induced Fani-Marlen Roumelioti Laboratory Genetics, Center Experimental Medicine and Translational Research, Biomedical Research Foundation the Academy Athens, Greece Search for more papers by this author Sotirios K Sotiriou Department Molecular Biology, University Geneva, Switzerland Vasiliki Katsini Maria Chiourea Thanos D...

10.15252/embr.201643169 article EN cc-by-nc-nd EMBO Reports 2016-10-19

Abstract Background Senescence is a fundamental biological process implicated in various pathologies, including cancer. Regarding carcinogenesis, senescence signifies, at least its initial phases, an anti-tumor response that needs to be circumvented for cancer progress. Micro-RNAs, subclass of regulatory, non-coding RNAs, participate regulation. At the subcellular level micro-RNAs, similar proteins, have been shown traffic between organelles influencing cellular behavior. The differential...

10.1186/s12864-017-4375-1 article EN cc-by BMC Genomics 2018-01-10

miRNAs constitute fine-tuners of gene expression and are implicated in a variety diseases spanning from inflammation to cancer. miRNA is deregulated rheumatoid arthritis (RA); however, their specific role key arthritogenic cells such as the synovial fibroblast (SF) remains elusive. Previous studies have shown that Mir221/222 upregulated RA SFs. Here, we demonstrate TNF IL-1β but not IFN-γ activated Mir221 /222 murine SF-specific overexpression huTNFtg mice led further expansion SFs disease...

10.7554/elife.84698 article EN cc-by eLife 2024-09-05

Ongoing chromosomal instability in neoplasia (CIN) generates intratumor genomic heterogeneity and limits the efficiency of oncotherapeutics. Neoplastic human cells utilizing alternative lengthening telomeres (ALT)-pathway, display extensive structural numerical CIN. To unravel patterns genome evolution driven by oncogene-replication stress, telomere dysfunction, or genotoxic therapeutic interventions, we examined comparative hybridization five karyotypically-diverse outcomes ALT osteosarcoma...

10.3390/cancers12030591 article EN Cancers 2020-03-05

Prostate cancer is one of the most common for men worldwide with advanced forms showing supernumerary or clustered centrosomes. Hematological and neurological expressed 1 (HN1) also known as Jupiter Microtubule Associated Homolog (JPT1) belongs to a small poorly understood family genes that are evolutionarily conserved across vertebrate species. The co-expression network HN1 from TCGA PRAD dataset indicates putative role in centrosome-related processes context prostate cancer. expression low...

10.1080/15384101.2021.1962624 article EN Cell Cycle 2021-08-12
Coming Soon ...